Mostly Markets
Subscribe
Stocks/Health Care/Life Sciences Tools & Services

Mettler ToledoMTD

Life Sciences Tools & Services · Columbus, Ohio · In the S&P 500
Solid businessPricier than peers
$1,674.81−2.55%After hours: $1,677.03 (+0.13%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 20.1% over 1 year
Mettler Toledo over 1 yearDaily close, $, to 30 Oct 2026
$1,000$1,200$1,400$1,600Nov2026MarMayJulSep$1,675$1,000$1,250$1,500NovMarJul$1,675
Source: Nasdaq daily closes
Market value$33.56B
Price to earnings37.7x
Forward P/E34.1x
Dividend yield–
Year to date+20.1%
One year+20.1%
Next earningsThu 5 Nov, after the close
SectorHealth Care
52-week range (closes)
$1,025.53$1,718.61

Quality and valuation

How Mettler Toledo compares with other health care stocks. A description, not a recommendation.

Mettler Toledo and 7 life sciences tools & services peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: pricier than most

An average business among health care companies, priced above most of them.

Mettler Toledo trades at 34.1 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +6.9% vs +7.8%
  • Keeps less of each sale (gross margin): 60.3% vs 65.3%
  • Turns more of its sales into cash: 20.9% vs 15.9%
  • Keeps more of its revenue as profit (net margin): 21.9% vs 9.7%
MTD trades at 34.1x forward earnings, above the sector medianForward p/e, Life Sciences Tools & Services peers
IQV19.8xDHR26.5xTMO26.6xA26.6xCRL29.1xWAT29.8xMTD34.1xILMN41.6xSector median 19.1xIQV19.8xDHR26.5xTMO26.6xA26.6xCRL29.1xWAT29.8xMTD34.1xILMN41.6xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 37.7x earnings, MTD is pricier than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
25x30x35x40xAverage 32.6x2025202637.7x30x40xAverage 32.6x2025202637.7x
Source: Nasdaq prices; SEC filings

Financials

From Mettler Toledo's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 4.5% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0.0bn$0.5bn$1.0bnQ3 ’24Q1 ’25Q3 ’25$1.0bnQ2 ’26$0.0bn$0.5bn$1.0bnQ3 ’24Q1 ’25Q3 ’25$1.0bnQ2 ’26
Source: SEC filings
Growth slowed to +4.5% last quarterRevenue growth, year on year, %
0%5%10%Q3 ’24Q1 ’25Q3 ’254.5%Q2 ’260%10%Q3 ’24Q1 ’25Q3 ’254.5%Q2 ’26
Source: SEC filings
Free cash flow was $864 million over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$100m$200mQ3 ’24Q1 ’25Q3 ’25$283mQ2 ’26$0m$100m$200mQ3 ’24Q1 ’25Q3 ’25$283mQ2 ’26
Source: SEC filings
Diluted EPS was $11.55 last quarterQuarterly diluted earnings per share, $
$0$5$10Q3 ’24Q1 ’25Q3 ’25$11.55Q2 ’26$0$5$10Q3 ’24Q1 ’25Q3 ’25$11.55Q2 ’26
Source: SEC filings
Last 12 monthsMTDSector median
Revenue growth+6.9%+7.8%
Gross margin60.3%65.3%
Free cash flow margin20.9%15.9%
Price to earnings37.7x30.2x

Stories on Mettler Toledo

We haven't written about Mettler Toledo yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Life Sciences Tools & Services, by market value.

CompanyPriceTodayYTDValue
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B
DHRDanaher$232.23−2.00%+1.4%$163B
AAgilent Technologies$174.87−3.47%+28.5%$49.30B
WATWaters$462.72−3.61%+21.8%$45.46B
IQVIQVIA$267.33−2.81%+18.6%$44.06B
ILMNIllumina$235.99−18.64%+79.9%$35.63B
CRLCharles River Laboratories$359.41−4.44%+80.2%$17.16B
TECHBio-Techne$72.66−0.07%+23.6%$11.41B